Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akoya Biosciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AKYA
Nasdaq
3841
https://www.akoyabio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akoya Biosciences Inc
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
- Apr 5th, 2024 12:00 pm
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript
- Mar 5th, 2024 2:52 pm
Q4 2023 Akoya Biosciences Inc Earnings Call
- Mar 5th, 2024 12:00 pm
Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook
- Mar 4th, 2024 10:31 pm
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
- Mar 4th, 2024 10:15 pm
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
- Mar 4th, 2024 9:05 pm
Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?
- Feb 29th, 2024 2:40 pm
Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m
- Feb 24th, 2024 12:57 pm
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
- Feb 13th, 2024 2:40 pm
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
- Feb 8th, 2024 9:05 pm
Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?
- Feb 7th, 2024 9:13 am
Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag
- Jan 31st, 2024 4:50 pm
Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?
- Jan 26th, 2024 2:40 pm
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
- Jan 18th, 2024 1:00 pm
Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions
- Jan 14th, 2024 2:02 pm
Are Medical Stocks Lagging Cigna Group (CI) This Year?
- Jan 10th, 2024 2:40 pm
Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
- Jan 10th, 2024 1:00 pm
Best Momentum Stocks to Buy for January 8th
- Jan 8th, 2024 3:00 pm
5 Small-Cap Stocks to Play the January Effect
- Jan 8th, 2024 2:59 pm
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
- Jan 7th, 2024 1:00 pm
Scroll